As psychedelics are being embraced as a potential treatment for mental health conditions, new research suggests that mind-altering substances like 'magic' mushrooms leave people feeling positive and socially connected hours after the high wears off.
The study by Yale University, surveying 1,200 Brits and Americans at six music festivals, provided evidence to support lab-based research that psychedelic drugs can boost wellbeing.
Between 2015 and 2017, teams of researchers set up "Play Games for Science" booths in busy areas at their selected festivals between 10 AM and 1 PM, encouraging people to come and speak to them. Participants spent 15 minutes filling out surveys on their use of psychoactive substances, as well as age, gender, level of religiousness, political orientation and level of education.
Each person was asked whether they'd had a transformative experience at the festival defined as "an experience that changes you so profoundly that you come out of the experience radically different than you were before the experience" and, if so, whether they enjoyed it.
Most of the participants were moderately liberal 30-year-olds who had attended four-year colleges. Some 80% of them drank alcohol at the festival, 50% used cannabis, and 26.6% used psychedelics. (Only 12.3% of festival goers reported taking zero substances.) Researchers only approached people who weren't noticeably drunk, and they put a question into their survey that functioned as a sobriety check, ruling out participants that were too drunk to answer correctly.
The researchers, led by neuroscientist Molly Crockett, found that the results were strongest in people who'd taken the drugs in the last 24 hours, though most seemed to be experiencing an "after glow" hours after the effects of the drugs should have worn off. They found people who'd taken psychedelics were more likely to feel positive, and some even experienced a shift in their moral values.
Crockett's team could not verify which drug each person was taking, how much of it, and whether it was mixed with other substances. But even their general findings were useful, echoing results in previous controlled laboratory studies that found psychedelics make us feel socially connected.
Crucially, they wanted to understand whether participants' expectations affected their 'high'. People taking psychedelics may have wanted or intended to have a transformative experience, Crockett told Insider, and the fact that attending an event might be a transformative experience even without psychedelics.
"We found that psychedelic use is associated with transformative experience over and above expecting and desiring such experiences," Crockett told Insider.
The study did not look at negative reactions beyond asking participants if their transformative experience had been positive or negative.
In the 1950s and 60s, psychedelic properties such as psilocybin (magic mushrooms) and lysergic acid diethylamide (LSD) were the subject of many scientific studies, but they fell out of favor as the drugs became associated with debauchery and hedonism.
Recently there's been a resurgence of scientific interest in the benefits of psilocybin. In 2018, researchers at John Hopkins, America's oldest research university,urged the federal government to legalize psilocybin.
Last year Johns Hopkins launched a center solely dedicated to psychedelics research. This came after a number of studies which looked at the effect psychedelics had on depression, anxiety, and obsessive compulsive disorder.
"Something with more immediate effects has a huge benefit as a tool in the therapeutic toolbox," Matthew Johnson, PhD, an associate professor of psychiatry and behavioral sciences, who authored his own psilocybin study, previously told Insider.
However, most research on the possible medical benefits of psychedelics takes place in a sterile lab environment, Crockett told Insider. It means scientists still don't have enough evidence to confirm if people will react to psychedelics in the real world the same way they would in a lab.
That's why Crockett led a group of researchers in visiting a bunch of music festivals, where psychedelics are often used to augment the musical experience, to find out what effect psychedelics might have in a natural setting.
"There is still a lot we don't understand about how psychedelics affect the brain and mind," Crockett told Insider. We need more research on how psychedelics "can be used to reduce suffering and enhance wellbeing, and how to minimize risks and potential negative effects associated with their use."
Researchers think magic mushrooms could have the potential to treat depression
A psychedelics expert says magic mushrooms will be approved for depression by 2027 here's why
Why psychedelics like magic mushrooms appear to kill the ego and fundamentally transform the brain
Read this article:
- Are NDEs caused by carbon dioxide overload? And what about psychedelics? - Patheos - June 24th, 2020
- ATAI dives into digital therapeutics to boost mental health care - FierceBiotech - June 24th, 2020
- 'People Should Have the Fundamental Right To Change Their Consciousness' - Reason - June 24th, 2020
- Revive Therapeutics betting on psychedelics and potential COVID-19 treatment Bucillamine - Proactive Investors USA & Canada - June 20th, 2020
- These Psychedelic Drugs May Be Key to Revolutionizing Weight Loss Treatment - Yahoo Finance - June 20th, 2020
- Champignon Brands CEO Dr Roger McIntyre authors studies appearing in two leading scientific journals - Proactive Investors USA & Canada - June 20th, 2020
- The effects of psychedelics on the brain's "consciousness conductor" - New Atlas - June 17th, 2020
- Psilocybin Dulls Activity in Brain Region Linked With Consciousness - Psych Congress Network - June 17th, 2020
- Champignon Brands revamps its brand identity to better reflect its scientific focus on psychedelic medicine - Proactive Investors UK - June 17th, 2020
- Mota Ventures Appoints Roger C. Clinton as Member of Advisory Board to Verrian GmbH - Its Psilocybin Research Subsidiary - Stockhouse - June 17th, 2020
- Cannabis Countdown: Top 10 Marijuana And Psychedelics Industry News Stories Of The Week - Yahoo Finance - June 13th, 2020
- New Psychedelics Stocks and Acquisitions | 2020-06-08 | Investing News - Stockhouse - June 13th, 2020
- Pure Extracts: The Second Wave of Psychedelic Operators - The Deep Dive - June 13th, 2020
- New analysis claims the FDA rushed ketamine's approval for depression treatment - Big Think - June 13th, 2020
- How Liv Vasquez Uses Plants & Food for Wellness and Healing - Thrillist - June 13th, 2020
- Companies are starting to bet big on psychedelic drugs to treat US mental health epidemic - Proactive Investors USA & Canada - June 6th, 2020
- CHECK IT OUT: New from Lady Gaga; take a wild ride; beach reading; and a screen gem - Wicked Local - June 6th, 2020
- Dr. Bronner's Soaps Wants to Protect You From COVIDand Legalize Your Right to Magic Mushrooms - Mother Jones - June 6th, 2020
- 6 celebrities wildest psychedelic trips, as told by themselves - Insider - INSIDER - June 1st, 2020
- Rate and Review: Have a Good Trip - The Independent Florida Alligator - June 1st, 2020
- First-of-Its-Kind Study Hints at How Psilocybin Works in The Brain to Dissolve Ego - ScienceAlert - June 1st, 2020
- Codebase says psychedelic investee Red Light Holland debuts on CSE with ticker TRIP - Proactive Investors USA & Canada - June 1st, 2020
- Todd Shapiro of Red Light Holland on 'magic truffles' and the multi-billion dollar psychedelics market - InvestorIntel - June 1st, 2020
- This Trippy Oregon Theme Park Is A Low-Key Psychedelic Playground - Thrillist - May 15th, 2020
- EGF Theramed Appoints George Anstey to Board of Directors - Benzinga - May 15th, 2020
- Empower Clinics and EuroLife Brands Close Definitive Agreement and Sign Multi-Year Multi-National Licence Agreement - GuruFocus.com - May 15th, 2020
- Have a Good Trip Demystifies Psychedelics - The New Republic - May 14th, 2020
- Investing in Psychedelics - Energy and Capital - May 14th, 2020
- Psilocybin May be the Key to Treating a Range of Health Issues, Including Obesity - Baystreet.ca - May 14th, 2020
- Movie review: Netflix's 'Have a Good Trip' is only a mild high - Eagle-Tribune - May 14th, 2020
- Psychedelics - Alcohol and Drug Foundation - May 10th, 2020
- Celebrities share LSD trips in Netflix documentary 'Have A Good Trip' - Insider - INSIDER - May 10th, 2020
- The Queen of Consciousness Driving Psychedelic Study and Advocacy - Filter - May 10th, 2020
- The 'Billions' Stock Watch: It's Time For Psychedelics And Subterfuge - UPROXX - May 10th, 2020
- Have a Good Trip: Netflix release and cast as celebrities recall mind-bending experiences - Mirror Online - May 10th, 2020
- From "Solar Opposites" to "Midnight Gospel," recent otherworldly animation is worth the head-trip - Salon - May 10th, 2020
- Netflix Reveals Celebrities' Wildest Drug Trips, From Anthony Bourdain to Carrie Fisher - The Daily Beast - May 10th, 2020
- Psychedelic mushrooms for depression: 'This is the one that changed things' - DW (English) - April 26th, 2020
- MindMed wants to develop a drug to help end a bad LSD trip - Fast Company - April 26th, 2020
- Netflixs The Midnight Gospel Is a Profoundly Weird Psychedelic Trip You Want To Take - Mashable India - April 26th, 2020
- Professor describes uses and history of hallucinogens - The Daily Evergreen - April 26th, 2020
- Media Central moves to provide coverage on emerging Psychedelics and eGames sectors - Proactive Investors USA & Canada - April 26th, 2020
- This video game does the same things to your brain as magic mushrooms - Happy Mag - April 26th, 2020
- Inborn Psychedelia on White Nights' Into the Lap of the Ancient Mother - Invisible Oranges - April 26th, 2020
- Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week - Yahoo Finance - April 9th, 2020
- Psychedelic mushrooms could affect the brain long after its active ingredient leaves the system - The Next Web - April 9th, 2020
- We Could Be Taking Psychedelics to Help Treat Mental Illness in Just Five Years - Newsweek - April 7th, 2020
- Magic mushrooms to treat depression? COMPASS Pathways pushes forward with U.S. patent for psilocybin therapy - Straight.com - April 7th, 2020
- Key Insights from PSYCH: The Psychedelics as Medicine Report - Prohibition Partners - March 18th, 2020
- Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week - Benzinga - March 18th, 2020
- With No Progress in Therapy, NYC Couple Turns to Psychedelics for Help - NBC New York - March 13th, 2020
- Upscale Psychedelics Therapy Center Opens On New Yorks 5th Avenue - Forbes - March 13th, 2020
- Why Kevin O'Leary is betting on psychedelics - Wealth Professional - March 13th, 2020
- Learning the hard way that psychedelic drug use can have long-term consequences - Dailyuw - March 13th, 2020
- Forget taking a pill a day. Canada is using psychedelics to revolutionize the way we treat mental health and addiction - The GrowthOp - March 13th, 2020
- High Stakes: Will The Legalization Of Psychedelics Mimic That Of Cannabis? Will It Learn From Its Mistakes? - Benzinga - March 13th, 2020
- Scientists Just Proved These Two Brain Networks Are Key to Consciousness - Singularity Hub - March 13th, 2020
- Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week - MarketWatch - March 13th, 2020
- Podcast Host Joe Rogan Is Steadily Documenting A Psychedelic Record Of The 21st Century - Forbes - February 27th, 2020
- Empower Clinics to create psilocybin and psychadelics division leveraging corporate wellness and franchise clinic network - Proactive Investors USA... - February 27th, 2020
- The Psilocybin Movement Is Like The Cannabis Movement (Except When It's Not) - Benzinga - February 27th, 2020
- Psychedelics and Their 'Mystical Effects' in the Real World - Medscape - January 22nd, 2020
- Psychedelic Events Are Going Mainstream, Where The Much-Maligned Mushroom Industry Focuses On Mental Health - Forbes - January 18th, 2020
- Psychedelics have 'extraordinarily potent' anti-inflammatory power. Is there a place for them in mainstream medicine? - Genetic Literacy Project - January 18th, 2020
- Silicon Valley Is Micro-Dosing Magic Mushrooms To Boost Their Careers - Forbes - January 18th, 2020
- NYC To Host Economics Of Psychedelics Investing Summit - Benzinga - January 18th, 2020
- The Best FREE Things to Do for the Next Week - My New Orleans - January 18th, 2020
- Photos of the Stuff That Fascinates People While They're Tripping On LSD - VICE - January 18th, 2020
- Rats on DMT hint at the benefits of psychedelic microdosing - Inverse - December 31st, 2019
- BEYOND LOCAL: Would you ever consider psychedelics to treat PTSD? - SooToday.com - December 31st, 2019
- A Trailblazer of Global Consciousness: Ram Dass Led the Way - Psychology Today - December 31st, 2019
- The Psychedelic Renaissance and the importance of drug policy reform - Open Access Government - December 13th, 2019
- Magic Mushrooms Move Closer to Mainstream Medicine As VC-Backed Compass Touts Safety, Positive Mood Alteration - Karma - December 13th, 2019
- Miami Clinics Use Ketamine IV Therapy to Help Treat Depression and PTSD - Miami New Times - December 13th, 2019
- Andy Frasco Talks Finding Emotional Balance With Psychedelics On 'Psychedelics Today' Podcast [Listen] - Live for Live Music - November 30th, 2019
- Will psychedelics be available commonly in the near future? - BPhrm Dv - November 30th, 2019
- Letters to the Editor: Psychedelics on their way - Valley Advocate - November 30th, 2019
- Scientists Have a Fascinating New Map of the Human Brain on DMT - VICE - November 30th, 2019
- Hes a fungi: U.S. health agency asks researcher to give it the lowdown on psilocybin mushrooms - The GrowthOp - November 30th, 2019
- A Magic Mushroom Test Case, and the Man Behind It - OZY - November 30th, 2019